MassDevice is liveblogging the MassMEDIC 11th Annual Medtech Investors Conference. We’re talking to the officers and executives of some of the hottest under-the-radar medical device firms around, finding out how and why their technologies will separate them from the pack.
RBCyte Inc., Walpole, Mass.
RBCyte’s automated blood collection system can process up to six units of whole blood simultaneously.
Officers
Jacques Chammas, President & CEO
Joseph Plante, EVP & COO
Melissa Lynch, EVP & CFO
Ronald Gilcher, Medical Director
Product
Automated Blood Collection System and Processing – Processes up to six units of whole blood simultaneously. Each blood unit is automatically separated into a unit of leukoreduced red cells mixed with additive solution, a large volume of leukoreduced plasma, and a whole blood derived platelet unit mixed with additive solution. Complete processing of all 6 units is accomplished within 24 minutes without operator intervention at a rate of 15 units per hour – a 75% reduction in cycle time compared to current manual methods.
A proprietary disposable set is used exclusively with the automated system for blood collection and processing. The disposable set contains all necessary bags, filters, and solutions.
